Business and Finance

Pharmaceutical Commerce sat down with Mr. Mortazavi recently; here's what he had to say.

Absence of agreed-on FDA guidance keeps biosimilars off the US market even as their use grows abroad

Battlefield over drug pricing

Blackstone Group-owned CDMO nets over $800 million

Outsourced contract-administration provider highlights growth in invoicing and financial stewardship burdens

Acquisition will add C3i's multilingual service-desk support to Telerx's call centers

Pharmaceutical Commerce sat down with Angela Miccoli, president, Cegedim Relationship Management NA since 2009. Here's what she had to say.

Annual IMS Institute survey finds generics level at 86%

2014 EMD Serono Specialty Digest: managing adherence programs are a sought-after service

Annual survey tracks rapid evolution in a critical pharma market

Better adherence could save $337 billion in healthcare costs

Cost-cutting will continue while marketplace demands a higher level of data quality from pharma

First of many meetings to come that are required by the Drug Supply Chain Security Act

Ernst & Young Firepower report sees a 'growth gap' for traditional pharmacos

Company's integration of Medco is 'largely complete'

Competitive forces sharpen as manufacturers look for the right channel partners

HDMA's 2013-14 Factbook updates member financial, operational performance

Will 'white bagging' and specialty-pharmacy business practices change distribution dynamics?

Growth includes 1-4% CAGR in US, 0-3% in Europe and 14-17% in China. US specialties have a twist

Both Revitas and Model N bring out enhanced script-validation modules to ensure rebate accuracy

New approaches, and new skill sets are necessary for meeting the challenges of global drug reimbursement policies

State-by-state, plan-by-plan analysis from CVS Caremark highlights multibillion-dollar savings if adherence rates are improved